Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis

Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis

Background: Warfarin is traditionally the drug of choice for stroke prophylaxis or treatment of venous thromboembolism in patients with end-stage renal disease (ESRD) on hemodialysis as data on apixaban use is scarce. We aimed to assess the safety and efficacy of Apixaban in patients with ESRD on he...

Full description

Bibliographic Details
Main Authors: Ghulam Murtaza, Mohit K. Turagam, Jalaj Garg, Urooge Boda, Krishna Akella, Poonam Velagapudi, Andrea Natale, Rakesh Gopinathannair, Dhanunjaya Lakkireddy
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Indian Pacing and Electrophysiology Journal
Subjects:
Apixaban
Warfarin
Dialysis
End-stage renal disease
Meta-analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S0972629221000565

Internet

http://www.sciencedirect.com/science/article/pii/S0972629221000565

Similar Items